Meta-analysis: overweight, obesity, and Parkinson's disease

Area of Science:

• Neurology
• Epidemiology
• Public Health

Background:

• Parkinson's disease (PD) is a severe neurological disorder with largely unknown risk factors.
• Investigating modifiable risk factors like body weight is crucial for understanding PD etiology.
• Previous studies on the association between overweight, obesity, and PD have yielded inconsistent results.

Purpose of the Study:

• To conduct a meta-analysis investigating the relationship between overweight and obesity and the risk of Parkinson's disease (PD).
• To synthesize evidence from existing cohort and case-control studies to determine the potential role of body mass index (BMI) in PD development.

Main Methods:

• Systematic literature search of PubMed, EMBASE, and CNKI databases up to September 30, 2013.
• Inclusion of four cohort studies and three case-control studies involving 2857 PD patients and 5,683,939 controls.
• Data analysis using RevMan5.2 and Stata11.0, categorizing participants by BMI: overweight (25 ≤ BMI < 30), obesity (BMI ≥ 30), and normal weight (BMI < 25).

Main Results:

• Cohort studies indicated a statistically significant increased risk of PD for overweight individuals (25 ≤ BMI < 30) compared to normal weight (RR = 1.17, P = 0.03).
• No significant association was found between obesity (BMI ≥ 30) and PD risk in cohort studies (RR = 1.16 for BMI ≥ 30 vs. BMI < 25; RR = 0.84 for BMI ≥ 30 vs. 25 ≤ BMI < 30).
• Case-control studies did not reveal any statistically significant differences in PD risk across BMI categories.

Conclusions:

• The meta-analysis suggests that being overweight (25 ≤ BMI < 30) may be a potential risk factor for developing Parkinson's disease.
• Obesity (BMI ≥ 30) was not significantly associated with PD risk in this analysis.
• Further research is needed to confirm a causal role of overweight/obesity in PD pathogenesis, which could inform therapeutic strategies.